Mark Andrew White - General Manager, Commercial Affairs at ROCKET PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
General Manager, Commercial Affairs
Issuer ticker
RCKT, RCKTW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Mark Andrew White since 14 Sep 2025

Reported holdings for Mark Andrew White in ROCKET PHARMACEUTICALS, INC.

Form 4 holding General Manager, Commercial Affairs

ROCKET PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
69,140
Estimated value
$1,149,453
Report date
31 Oct 2024
Price
$16.62
Ownership
Direct
Form 4 holding General Manager, Commercial Affairs

ROCKET PHARMACEUTICALS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
32,727
Estimated value
$410,724
Report date
16 Feb 2024
Price
$12.55
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Mark Andrew White in ROCKET PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .